切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2008, Vol. 04 ›› Issue (06) : 567 -570. doi: 10.3877/cma.j.issn.1673-5250.2008.06.112

论著

罗哌卡因用于患儿骶管阻滞术后镇痛的临床观察
陈本祯, 姚玉笙, 骆丽慧, 谭玲   
  1. 四川省妇幼保健院麻醉科
    四川大学华西医院麻醉科(成都,610041)
  • 出版日期:2008-12-01

Caudal Block Postoperative Analgesia Effect of Ropivacaine on Subumbilical Surgery Children

Ben-zhen CHEN, Yu-sheng YAO, Li-hui LUO, Ling TAN   

  1. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China
  • Published:2008-12-01
引用本文:

陈本祯, 姚玉笙, 骆丽慧, 谭玲. 罗哌卡因用于患儿骶管阻滞术后镇痛的临床观察[J]. 中华妇幼临床医学杂志(电子版), 2008, 04(06): 567-570.

Ben-zhen CHEN, Yu-sheng YAO, Li-hui LUO, Ling TAN. Caudal Block Postoperative Analgesia Effect of Ropivacaine on Subumbilical Surgery Children[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2008, 04(06): 567-570.

目的

观察1~3岁患儿骶管阻滞术后应用不同浓度罗哌卡因进行术后镇痛的临床效果。

方法

纳入对象为2007年在四川大学华西医院择期行腹股沟区手术的80例1~3岁患儿。将其随机分为四组,吸人诱导下用静脉留置针行骶管穿刺,并留置套针于骶管腔,固定于患儿骶尾部,先注入1%利多卡因1 mL/kg至骶管腔,1 h后再注入不同药液(A, B, C组分别注入0. 075%,0.100%,0.125%罗哌卡因,D组注人生理盐水)1 mL/kg(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准,得到该委员会批准,取得受试对象的知情同意,并与试验患儿监护人签署临床研究知情同意书)。

结果

A,B,C和D组患儿术后镇痛持续时间分别为的5. 13 h(95 %CI 3. 90 h~6. 36 h), 7. 20 h(95 %CI 6.46 h~7. 94 h), 7. 65 h(95 %CI 7.25 h~8. 05 h),3. 78 h(95%CI 2.45 h~5. 10 h)。四组患儿术后镇痛持续时间总体比较,差异有显著意义(P<0. 01);B组和C组比较,差异无显著意义(P>0. 05);A组和D组比较,差异无显著意义(P>0. 05)。A,B,C和D组患儿术后24 h内需要镇痛处理的病例数分别为11例、4例、3例和14例。

结论

0.100%罗哌卡因1 mL/kg骶管阻滞可为1~3岁下腹壁手术患儿提供满意的术后早期镇痛。

Objective

To evaluate dose range on analgesic effect on ropivacaine in pediatric caudal anesthesia.

Methods

Eighty American Society of Anesthesiologist(ASA)physical status I children, aged 1 ~3 years, were admitted in West China Hospital, Sichuan University in 2007. They were randomly divided into four groups according to the varied ropivacaine concentration. After the sevoflurane inhalation induction, caudal injection was performed by a fixed catheter. As the basic anesthesia, 1 % lidocaine(1 mL/kg)was infused. One hour later, ropivacaine was given at different concentrations(1 mL/kg)to the group A(0. 075%), the group B(0. 100%), the group C(0. 125%). The group D children were the control group with saline solution(1 mL/kg). Informed consent was obtained from all participants. The major outcomes, like the analgesia duration and the numbers needed to treat were recorded after operation. Additional analgesia in the following 24 h was assessed by an independent expert of the Children and Infants Postoperative Pain Scale(CHIPPS)on the ward, and would be carried out once the Children and Infants Postoperative Pain Scale scores higher than or equal to four. Improved Bromage score was used to evaluate the lower limb motor blockade. The postoperative analgesia duration among different groups were calculated by Kanplan-Meimer survival analysis with the statistical inference at 0. 05.

Results

Four groups had no significant difference with respect to the patient age, height, weight and surgical procedures. The postoperative analgesia duration of A, B, C and D groups were 5. 13 h(95%CI3. 90 h~6. 36 h), 7. 20 h(95 %CI 6. 46 h~7. 94 h), 7. 65 h(95%CI7. 25 h~8. 05 h)and 3. 78 h(95 %CI 2.45 h~5. 10 h), respectively. There was a significant difference among four groups(P<0. 01)and no difference between the group B and the group C(P>0. 05). Cases for additional analgesia were 11, 4, 3 and 14 in four groups.

Conclusion

Caudal ropivacaine 0. 100% can provide satisfactory postoperative analgesia for children undergoing elective sub-umbilical surgery at 1~3 years old.

图1 患儿术后罗哌卡因的镇痛持续时间生存曲线(Kaplan Meimer法)
1 Albright GA. Cardiac arrest following regional anesthesia with etidocaine and bupivacaine. Anesthesiology,1979, 51:285-287.
2 Reiz S,Nath S. Cardiotoxicity of local anesthetic agents. Br J Anaesth, 1986, 58:736-746.
3 Knudsen K,Beckman M,Suukula M, et al. Central nervous and cardiovascular effects of i. v. infusions of ropivacaine,bupivacaine and placebo in volunteers. Br J Anaesth,1997,78:507-514.
4 Scott DB, Lee A,Fagan D,et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg,1989,69:563-569.
5 Karmakar MK,Aun CS,Wong EL,et al. Ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than bupivaeaine. Anesth Analg,2002,94(2):259-265.
6 Ala-Kokko TI, Partanen A, Karinen J,et al. Pharmacokinetics of 0.2% ropivacaine and 0. 2% bupivacaine following caudal blocks in children. Acta Anaesthesiol Scand, 2000,44:1099-1102.
7 Jin QY, Xu Y. Efficacy of combination of caudal block and general anesthesia on sub-umbilical surgery in neonates. Chin J Anesthesiol, 2001,21 : 313-314.[金全英,徐莹.骶管阻滞联合浅全麻用于新生儿腹部手术的临床观察.中华麻醉学杂志,2001,21: 313-314.]
8 Dalens B, Hasnaoui A. Caudal anesthesia in pediatric surgery:Success rate and adverse effects in 750 consecutive patients. Anesth Analg,1989,68:83-89.
9 Bosenberg AT,Thomas J, Lopez T, et al. Plasma concentrations of ropivacaine following a single-shot caudal block of 1,2 or 3 mg/kg in children. Acta Anaesthesiol Scand,2001,45:1276-1280.
10 Hansen TG,Ilett KF, Lim SI,et al. Pharmacokinetics and clinical efficacy of long-term epidural ropivacaine infusion in children. Br J Anaesth, 2000,85:347-353.
11 Habre W,Bergesio R,Johnson C. Pharmacokinetics of caudal ropivacaine following caudal analgesia in children. Paediatr Anaesth,2000,10:143-147.
12 Buttner W,Finke W. Analysis of behavioral and physiological parameters for the assessment of postoperative analgesic demand in newborns,infants and young children:A comprehensive report on seven consecutive studies. Pediatr Anaesth, 2000,10:303-318.
13 Ivani G,DeNegri P, Conio A, et al. Comparison of racemic bupivacaine, ropivacaine,and levo-bupivacaine for pediatric caudal anesthesia:Effects on postoperative analgesia and motor block. Reg Anesth Pain Med,2002,27:157-161.
14 Andrews K,Fitzgerald M. Cutaneous flexion reflex in human neonates:A quantitative study of threshold and stimulus-response characteristics after single and repeated stimuli. Deo Med Child Neurol,1999,41:696-703.
15 Sittl R,Griebinger N,Koppert W,et al. Management of postoperative pain in children. Schmerz, 2000,14:333-339.
16 Howard RF. Current status of pain management in children. JAMA,2003, 12:464-469.
17 Wolf AR, Valley RD, Fear DW, et al. Bupivacaine for caudal analgesia in infants and children:The optimal effective concentration. Anesthesiology,1988,69:102-106.
18 Bader AM, Datta S,Flanagan H, et al. Comparison of bupivacaine and ropivacaine induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg,1989,68:724-727.
19 Feldman HS, Co vino BG. Comparative motor blocking effects of bupivacaine and ropivacaine, a new local anesthetic in the rat and dog. Anesth Analg,1988,67:1047-1052.
20 Akerman B,Hellberg IB, Trossvik G. Primary evaluation of the local anesthetic properties of the amino amide agent ropivacaine. Acta Anaesthesiol Scand, 1988, 32:571-578.
21 Geradini G,Samuelson U,Jernbeck J, et al. Comparison of vascular effects of ropivacaine on isolated rings of human arteries. Acta Anaesthesiol Scand,1995,39:765-768.
22 Kopacz DJ, Carpenter RL, Mackey DC. Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology,1989,71:69-74.
23 Nakamura K,Toda H, Kakuyama M,et al. Direct vascular effects of ropivacaine in femoral artery and vein of the dog. Acta Anaesthesiol Scand,1993, 37:269-273.
24 Gunter JB. Benefit and risks of local anesthetics in infants and children. Paediatr Drugs, 2002,4:649-672.
25 Kohane DS, Lu NT, Gokgol-Kline AC,et al. The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo. Regional Anesth Pain Med,2000,25:52-59.
26 Borgeat A, Blumenthal S. Nerve injury and regional anaesthesia. Curr Opin Anaesthesiol,2004,17:417-421.
27 Kitagawa N,Oda M,Totoki T. Possible mechanism of irreversible nerve injury caused by local anesthetics detergent properties of local anesthetics. Anesthesiology,2004,100:962-967.
28 Deng XM, Xiao WJ, Tang GZ,et al. The minimum local anesthetic concentration of ropivacaine for caudal analgesia in children. Anesth Analg, 2002,94:1465-1468.
[1] 梁潇, 黄绍农, 赵聚钊, 陈志聪, 朱耀旻, 王昱萌. 右美托咪定复合罗哌卡因局部浸润对颞下颌关节术后疼痛及恶心呕吐的影响[J]. 中华口腔医学研究杂志(电子版), 2023, 17(01): 49-54.
[2] 李志伟, 向琪, 彭胜男, 郭玲, 孙贱根, 杨川. 右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用[J]. 中华普通外科学文献(电子版), 2023, 17(03): 182-185.
[3] 赵静涵, 陈玉龙, 张琛. 超声参数与UPJO致肾积水患儿肾功能的相关性分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 372-376.
[4] 黄铁刚, 肖凤霞. 地塞米松联合罗哌卡因在腹股沟疝修补术后镇痛效果及对血清指标的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 574-578.
[5] 彭涛, 吴志福, 张俊生. 骶管阻滞复合全身麻醉在腹股沟斜疝患儿腹腔镜手术中的效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 449-453.
[6] 李志全, 王茜, 赵泽宇. 单用喉罩全身麻醉或联合骶管阻滞在儿童疝囊高位结扎术中的效果比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(03): 322-325.
[7] 孙邦峰, 崔振华, 马斌. 不同浓度罗哌卡因在腹股沟疝修补术中麻醉及镇痛效果对比[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(01): 65-69.
[8] 吕鹏龙, 张丹妮, 郝春光, 任玲. 右美托咪定联合不同浓度罗哌卡因局部神经阻滞在老年腹股沟疝无张力修补术中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(05): 578-582.
[9] 张伶俐, 汪俊, 姚琼. 罗哌卡因骶管阻滞对小儿腹腔镜疝囊高位结扎术的影响分析[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(04): 421-424.
[10] 李晓伟, 袁晓光, 孙蕾, 支小军, 张丹妮. 不同剂量罗哌卡因联合利多卡因对腹股沟疝无张力修补术后麻醉效果及应激反应的影响[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(04): 413-416.
[11] 方辉强, 黄杰, 何国安, 罗云, 何彦菲. 右美托咪定复合罗哌卡因对腹腔镜疝修补术老年患者神经阻滞效果的影响[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(03): 282-285.
[12] 邬杰忠, 柯春连, 李宇翠, 谭雷, 黄河, 熊志勇, 梁豪, 张鹏, 王庆亮, 许世磊, 林继宗, 胡昆鹏, 姚志成, 刘波. 帕瑞昔布联合罗哌卡因在腹腔镜胆囊切除术后早期镇痛中的疗效[J]. 中华肝脏外科手术学电子杂志, 2022, 11(04): 395-400.
[13] 周立杰, 王现雷, 吴振宇, 刘文超, 于洋. 超声引导下不同位置收肌管阻滞用于老年全膝关节置换术后的镇痛效果观察[J]. 中华老年骨科与康复电子杂志, 2022, 08(06): 367-373.
[14] 李明杰, 王雄. 局部麻醉对腹腔镜阑尾切除术后疼痛的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 266-270.
[15] 丁倩, 王谦, 郭春彦, 张怡, 梁宇光. 基于SWOT分析法探讨儿科临床药师在药物临床研究中的作用[J]. 中华临床医师杂志(电子版), 2023, 17(05): 581-586.
阅读次数
全文


摘要